Significant Endothelin Release in Patients Treated with Foam Sclerotherapy
- 1 May 2012
- journal article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 38 (5) , 741-747
Abstract
Foam sclerotherapy has been proven to be a safe and effective treatment for superficial venous insufficiency, but transient visual and neurologic disturbances continue to be reported. These side effects have been theorized to be related to the presence of air or gases in the sclerosing foam that results in "bubble" migration into the cerebral circulation. We present a differing hypothesis that significant amounts of endothelin are released from the treated veins, amounts capable of causing these complications. We tested the release of endothelin 1 (ET-1) in 12 rats after sclerotherapy with sodium tetradecyl sulfate (STS) in liquid and foam preparations. In 11 human subjects, we measured ET-1 in systemic circulation and in a draining vein after foam sclerotherapy with polidocanol. Rats treated with STS showed a significant increase in ET-1 levels 1 and 5 minutes after foam sclerotherapy. Patients treated with foam sclerotherapy showed a marked increase in ET-1 levels that correlated significantly with local ET-1 levels. Evidence of ET-1 release represents a plausible relationship explaining neurologic and visual disturbances reported after sclerotherapy.Keywords
This publication has 38 references indexed in Scilit:
- Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous refluxJournal of Vascular Surgery, 2010
- Ultrasound-guided foam sclerotherapy: safety and efficacyPhlebology: The Journal of Venous Disease, 2009
- Results of Surgical Treatment Compared with Ultrasound-Guided Foam Sclerotherapy in Patients with Varicose Veins: A Prospective Randomised StudyEuropean Journal of Vascular and Endovascular Surgery, 2009
- Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veinsBritish Journal of Surgery, 2009
- Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicentre Randomised Controlled Trial with a 2-year Follow-upEuropean Journal of Vascular and Endovascular Surgery, 2008
- Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical TrialEuropean Journal of Vascular and Endovascular Surgery, 2008
- The Use of Foam Sclerotherapy for Varicose Veins: A Survey of the Members of the Vascular Society of Great Britain and IrelandEuropean Journal of Vascular and Endovascular Surgery, 2007
- Foam Sclerotherapy Combined with Surgical Treatment for Recurrent Varicose Veins: Short Term ResultsEuropean Journal of Vascular and Endovascular Surgery, 2007
- Outcomes and Side effects of Duplex-Guided Sclerotherapy in the Treatment of Great Saphenous Veins with 1% versus 3% Polidocanol Foam: Results of a Randomized Controlled Trial with 1-Year Follow-UpDermatologic Surgery, 2007
- Outcome of Ultrasound-guided Sclerotherapy for Varicose Veins: Medium-term Results Assessed by Ultrasound SurveillanceEuropean Journal of Vascular and Endovascular Surgery, 2007